FBI searches national Covid testing facility that charged government $120m for testing uninsured Americans

Consumers complained that their tests were late, with some questioning whether testing was being done at all

Graig Graziosi
Monday 24 January 2022 21:36
Comments

Related video: Texas woman waits 18 hours in line for covid test

Leer en Español

The FBI executed a search warrant at the Chicago-area headquarters of a nation-wide pop-up Covid testing company called the Centre for Covid Control, according to a spokesperson for the US Department of Health and Human Services Inspector General.

USA Today first reported that federal agents searched a facility in Rolling Meadows, Illinois, on Saturday.

The company reportedly has the same registered address as a laboratory operating under the name Doctors Clinical Laboratory that distributed thousands of PCR tests that used specimens collecting from the testing company.

Despite the shared addresses, the testing company insisted to NBC News that the lab and the company were separate entities.

The Independent has reached out to the company for comment.

Both the testing company and the lab have been under investigation by the federal Centres for Medicare and Medicaid Services as well as by several state attorneys general.

According to federal records, the company has billed the government more than $120m for testing uninsured Americans.

A spokesman representing the Illinois attorney general confirmed that the office was working with federal law enforcement to investigate the company.

“We are working with the FBI and other law enforcement partners and will not comment on ongoing investigations as we work to hold accountable individuals who engage in unlawful conduct,” the spokesperson said.

The company suspended its operations on 13 January amid growing complaints, and said it planned to re-open on 22 January, which was the day the search was executed.

The complaints ranged from late test results to concerns that there was no actual testing being done at all.

Ryan Jacobson, a lawyer hired to represent the company, told NBC News that they are working "closely" with investigators to resolve the situation.

“We are working closely with authorities to provide information and shed light on the operational challenges [Center for Covid Control] experienced at the height of the Omicron surge, which no doubt contributed to consumer complaints and public scrutiny,” he said.

The testing company grew over the course of 2021 and eventually expanded to 300 sites across the US.

Investigations into the lab and the company began in November after an inspection revealed numerous violations, including unlabeled specimens.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Please enter a valid email
Please enter a valid email
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Must be at least 6 characters, include an upper and lower case character and a number
Please enter your first name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
Please enter your last name
Special characters aren’t allowed
Please enter a name between 1 and 40 characters
You must be over 18 years old to register
You must be over 18 years old to register
Opt-out-policy
You can opt-out at any time by signing in to your account to manage your preferences. Each email has a link to unsubscribe.

By clicking ‘Create my account’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Register for free to continue reading

Registration is a free and easy way to support our truly independent journalism

By registering, you will also enjoy limited access to Premium articles, exclusive newsletters, commenting, and virtual events with our leading journalists

Already have an account? sign in

By clicking ‘Register’ you confirm that your data has been entered correctly and you have read and agree to our Terms of use, Cookie policy and Privacy notice.

This site is protected by reCAPTCHA and the Google Privacy policy and Terms of service apply.

Join our new commenting forum

Join thought-provoking conversations, follow other Independent readers and see their replies

Comments

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in